GeneDx Holdings Corp vs Zoom Video Communications, Inc. — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while Zoom Video Communications, Inc. trades at $89.51 (market cap $26.66B). The key difference: Zoom Video Communications, Inc. is far larger — about 14.8× GeneDx Holdings Corp's market cap, and Zoom Video Communications, Inc. is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| WGS | ZM | |
|---|---|---|
Market Cap | $1.80B | $26.66B |
Sector | Technology | Technology |
52-Week High | $167.51 | $111.88 |
52-Week Low | $34.51 | $69.77 |
Enterprise Value | $1.80B | $19.00B |
Signals from Pluang's Aura AI — not financial advice
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
Zoom Communications (ZM) trades at $89.77, down 1.49% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with 77.4% gross margins and 42% net income margins, while recent AI-focused acquisitions and APAC leadership appointments signal growth initiatives. Q1 2026 earnings beat expectations with $1.55 EPS versus $1.42 expected.
Investment outlook remains positive with a $118.79 consensus price target offering 32% upside potential, though risks include competitive pressure from Microsoft and Google, insider selling activity, and fluctuating cash flow trends. Wall Street sentiment is mixed with 39% buy ratings versus 55% hold recommendations.
Trailing returns across standard periods
Latest headlines on both assets
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →